β-Protein immunoreactivity in the human brain after cardiac arrest

Folia Neuropathologica

Volumn 34, Issue 2, 1996, Pages

  Wiśniewski, Henryk M ^a   Maślińska, Danuta ^a,b  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Alzheimer disease; Beta amyloidosis; Cardiac arrest; Fibrillogenesis; Human; Plaques

Indexed keywords

EID: 3142585346     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Anderson J, Chen Y, Kim K, Robakis N: An alternative secretase cleavage produces soluble Alzheimer amyloid precursor protein containing a potentially amyloidogenic sequence. J Neurochem, 1992, 59, 2328-2331.
2. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, et al.: Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzmeimer's disease. Brain Res, 1989, 477, 90-99.
3. Bancher C, Grundke-Iqbal I, Iqbal K, Kim KS, Wisniewski HM: Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid β-protein. Neurobiol Aging, 1989, 10, 125-135.
4. Esch FS, Keim Ps, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, et al: Cleavage of amyloid β peptide during constitutive processing of its precursor. Science, 1990, 248, 1122-1124.
5. Games D, Khan KH, Soriano FG, Lieberburg I, Sinha S: Evidence for altered APP processing following acute head trauma in the rodent. Soc Neurosci Abst 1992, 22, 1437.
6. Glenner GG, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun, 1984, 120, 885-880.
7. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG: Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science, 1992, 255, 728-730.
8. Haass C, Schlossmacher M, Hung A: Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature, 1992, 359, 322-325.
9. Hardy J, Allsop D: Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci, 1991, 12, 383-388.
10. Kawarabayashi T, Shoji M, Harigaya Y, Yamaguchi H, Hirai S: Expression of APP in the early stage of brain damage. Brain Res, 1990, 563, 334-339.
11. Kim KS, Miller DL, Sapienza VJ, Chen CMJ, Bai C, Grundke-Iqbal I, et al.: Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun, 1988, 2, 121-130.
12. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB: Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest, 1987, 57, 230-236.
13. Martin LJ: Cellular dynamics of senile plaque formation and amyloid deposition in cerebral cortex: an ultrastructural study of aged nonhuman primates. Neurobiol Aging, 1993, 14, 681-683.
14. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down's syndrome. Proc Natl Acad Sci USA, 1985, 82, 4245-4249.
15. Nakamura Y, Takeda M, Niigawa H, Hariguchi S, Nishimura T: Amyloid - β protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection. Neurosci Lett, 1992, 136, 95-98.
16. Otsuka N, Tomomage M, Ikeda K: Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res, 1991, 568, 335-338.
17. Potempska A, Styles J, Mehta P, Kim KS, Miller DL: Purification and tissue level of the β-amyloid peptide precursor of rat brain. J Biol Chem, 1991, 266, 8464-8469.
18. Price DL: Overview of neuropathology in aged monkeys. Neurobiol Aging, 1993, 14, 685-686.
19. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al.: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA, 1993, 90, 9649-9653.
20. Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC, Oltersdorf T: β-amyloid precursor protein of Alzheimer disease occurs as 110- to 135 kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA, 1988, 85, 7341-7345.
21. Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, et al.: Secretion of-amyloid precursor protein cleaved at the amino terminus of the b-amyloid peptide. Nature, 1993, 361, 260-263.
22. Seubert P, Vigo-Pelfrey C, Esch F: Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature, 1992, 359, 325-327.
23. Shigematsu K, McGeer PL: Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine. Am J Pathol, 1992, 140, 787-794.
24. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, et al.: Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science, 1992, 258, 126-129.
25. Sparks DL, Hunsaker JC, Scheff WS, Kryscio RJ, Henson JL, Markesbery WR: Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging, 1990, 11, 601-607.
26. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, et al.: Binding of human apolipoprotein E to synthetic β-amyloid peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA, 1993, 90, 8098-8102.
27. Wallace WC, Bragin V, Robakis NK, Sambamurti K, Vander-Putten D, Merril CR, et al.: Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert. Brain Res, 1991, 10, 173-178. 28.
28. Wallace W, Ahlers ST, Gotib J, Bragin V, Sugar J, Gluck R, et al.: Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc Natl Acad Sci USA, 1993, 90, 8712-8716.
29. Westergaard E, Go G, Klatzo I, Spatz M: Increased permeability of cerebral vessels to horseradish peroxidase induced by ischemia in Mongolian gerbils. Acta Neuropathol, 1976, 35, 307-325.
30. Wang R, Maschia JF, Cotter RJ, Sisodia SS: Secretion of the b/A4 amyloid precursor protein. J. Biol Chem, 1991, 266, 16960-16964
31. Wiśniewski HM, Currie JR, Barcikowska M, Alzheimer's disease, a cerebral form of amyloidosis. In: Immunology and Alzheimer's Disease. Eds. Pouplard-Barthelaix A, Emile J, Christen Y. Paris, Springer-Verlag, 1988, 1-6.
32. Wiśniewski HM, Mehta PD, Kim KS, Merz GS: Cerebrospinal fluid-based laboratory test for Alzheimer disease. In: Biological Markers of Alzheimer's Disease. Eds: Boller R, Katzman R, Rascol JL, et al. Berlin, Heidelberg, Springer Verlag, 1989, 23-29, 33.
33. Wisniewski T, Frangione B: Apolipoprotein E: a pathological chaperon protein in patients with cerebral and systemic amyloid. Neurosci Lett, 1992, 135, 235-238.
34. Wiśniewski HM, Wȩgiel J, Wang KC, Lach B: Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol, 1992, 84, 117-127.
35. Wiśniewski HM, Wȩgiel J: Migration of perivascular cells into the neuropil and their involvement in β-amyloid plaque formation. Acta Neuropathol, 1993, 85, 586-595.
36. Wiśniewski HM, Fra̧ckowiak J, Żołtowska A, Kim KS: Vascular β-amyloid in Alzheimer disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid Intl J Exp Clin Invest, 1994, in press.
37. Wiśniewski HM, Wȩgiel J: β-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol, 1994, in press.